- Umbilical vein varix
- Timing of Cranial Markers in Open NTD
- Real world experience Open Neural tube defect and Brain Signs
- Real world experience First Trimester Megacystis – Management
- Real world experience Fetal Megacystis
- Abnormal facial profile
- Azygous Vein & ARSA
- Blakes Pouch Cyst
- Absent nasal bone (ANB)
- Choroid plexus cysts
- Chronic placental abruption
- Fetal Alcohol Syndrome
- Placenta-First Risk Stratification
Absent Nasal Bone
Absent nasal bone (ANB) is one of the strongest prenatal soft markers for aneuploidy, and unlike hypoplasia, its significance is largely independent of ethnicity.
What does “absent nasal bone” mean?
• True non-visualization of the nasal bone on a correct mid-sagittal view
• Skin over the nose is visible, but no echogenic ossified nasal bone
A nasal bone absent in the first trimester may appear later, but persistent absence increases concern.
Critical distinction
Ethnicity affects hypoplastic nasal bone far more than absent nasal bone.
Population data (approximate)
• Prevalence of absent NB in euploid fetuses: ~0.1–0.5%
• Minor ethnic variation exists, but predictive value remains high
| Ethnicity | Effect on significance |
|---|---|
| South Asian | Slightly higher prevalence, but still abnormal |
| East Asian | Same |
| African | Same |
| Caucasian | Same |
Absent nasal bone is concerning in all ethnic groups.
A. Aneuploidy (primary association)
Trisomy 21 (Down syndrome)
• Strongest link
• Absent NB seen in:
o ~60–70% in first trimester
o ~40–50% in second trimester
• Likelihood ratio: ~20–30
Pathogenic copy number variants if associated with:
• Abnormal facies
• Cardiac defects
• CNS anomalies
• 22q11.2 deletion
• Wolf–Hirschhorn syndrome (4p–)
• Cri-du-chat (5p–)
Investigations (what to offer)
First-line
• Invasive testing recommended
• Chromosomal microarray preferred over karyotype
Role of NIPT
• Acceptable if parents decline invasive testing
• Not definitive in presence of ANB
Key take-home points
• Absent nasal bone is one of the strongest soft markers
• Ethnicity does not neutralize its significance
• Isolation does not equal reassurance
• Invasive genetic testing should be offered
• Prognosis depends on the underlying diagnosis
First-tier ultrasound parameters
A. Nuchal markers
| Parameter | Why it matters | Red flag |
|---|---|---|
| NT (1st trimester) | Strongly additive risk with absent NB | NT ≥95th centile |
| Nuchal fold (2nd trimester) | Most powerful soft marker | ≥6 mm |
| Generalized skin edema | Suggests aneuploidy or hydrops | Any diffuse thickening |
B. Facial profile assessment
| Parameter | Interpretation |
|---|---|
| Midface hypoplasia | Strong T21 association |
| Flat facial profile | Seen in T21, some skeletal dysplasias |
| Premaxillary protrusion | Supports T21 |
| Retrognathia / micrognathia | Think T18, triploidy, syndromes |
Second-tier structural survey
A. Cardiac evaluation
| Finding | Significance |
|---|---|
| AVSD | Strong T21 marker |
| VSD (esp inlet) | Additive risk |
| Outflow tract anomalies | Syndromic suspicion |
| Abnormal ductus / arch | Think T22q11, T18 |
B. CNS markers
| Marker | Suggests |
|---|---|
| Ventriculomegaly | T21, T18 |
| Enlarged CSP | T21 |
| Absent / hypoplastic CC | Syndromic |
| Posterior fossa anomaly | T18, Joubert spectrum |
C. Limbs and skeleton
| Parameter | Why |
|---|---|
| Short femur/humerus | Classic T21 marker |
| 5th finger clinodactyly | T21 |
| Overlapping fingers | T18 |
| Foot–FL ratio | Excludes skeletal dysplasia |
3. Placental and growth context
| Parameter | Interpretation |
|---|---|
| Early FGR | T18, triploidy |
| Abnormal placental morphology | Triploidy |
| Oligohydramnios | T18, renal syndromes |
| Polyhydramnios | T21 (late), GI obstruction |
4. Doppler modifiers
| Doppler | Meaning |
|---|---|
| Absent/reversed DV a-wave (1st trimester) | High aneuploidy risk |
| Abnormal tricuspid flow | T21 |
| Normal Dopplers | Risk reduction in isolated cases |
Risk stratification summary (console-ready)
Low risk
• Isolated absent NB
• Normal NT/NF
• Normal cardiac + anatomy
• Low-risk NIPT
Intermediate risk
• Absent NB + 1 additional soft marker
• Normal anatomy otherwise
High risk
• Absent NB +
o Increased NT/
o Cardiac defect
o Multiple soft markers
o Structural anomaly